Gender differences in diet-induced steatotic disease in Cyp2b-null mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gender differences in diet-induced steatotic disease in Cyp2b-null mice
Authors
Keywords
Fatty liver, Gene expression, Fibrosis, Gene ontologies, Inflammation, Mouse models, Diet, Steatosis
Journal
PLoS One
Volume 15, Issue 3, Pages e0229896
Publisher
Public Library of Science (PLoS)
Online
2020-03-11
DOI
10.1371/journal.pone.0229896
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis
- (2019) Melissa M Heintz et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- High fat diet induced obesity is mitigated in Cyp3a-null female mice
- (2018) Ramiya Kumar et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians
- (2017) Chih-Hsuan Yen et al. PLoS One
- Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH
- (2017) Hui Li et al. TOXICOLOGICAL SCIENCES
- Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice
- (2017) Ramiya Kumar et al. PLoS One
- Fox transcription factors: from development to disease
- (2016) Maria L. Golson et al. DEVELOPMENT
- Persistent Chromatin Modifications Induced by High Fat Diet
- (2016) Amy Leung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- InterPro in 2017—beyond protein family and domain annotations
- (2016) Robert D. Finn et al. NUCLEIC ACIDS RESEARCH
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Cytoplasmic vacuolization in cell death and survival
- (2016) Andrey V. Shubin et al. Oncotarget
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Orchestrating high-throughput genomic analysis with Bioconductor
- (2015) Wolfgang Huber et al. NATURE METHODS
- Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver
- (2015) Poonamjot Deol et al. PLoS One
- Lipid-Metabolizing CYPs in the Regulation and Dysregulation of Metabolism
- (2014) David Bishop-Bailey et al. Annual Review of Nutrition
- Quercetin decreases high-fat diet induced body weight gain and accumulation of hepatic and circulating lipids in mice
- (2014) E. F. Hoek-van den Hil et al. Genes and Nutrition
- An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
- (2013) Masahiko Matsumoto et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Unknown
- (2013) Astrid Spruss et al. MOLECULAR MEDICINE
- Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity
- (2013) Irina Mikhailovna Bochkis et al. Molecular Metabolism
- Cholesterol and nonalcoholic fatty liver disease: Renewed focus on an old villain
- (2012) Thomas A. Kerr et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century
- (2011) Tanya L Blasbalg et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Anandamide Oxidation by Wild-Type and Polymorphically Expressed CYP2B6 and CYP2D6
- (2011) C. Sridar et al. DRUG METABOLISM AND DISPOSITION
- REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
- (2011) Fran Supek et al. PLoS One
- Lentiviral-Mediated RNAi Knockdown Yields a Novel Mouse Model for Studying Cyp2b Function
- (2011) Basma Damiri et al. TOXICOLOGICAL SCIENCES
- Tissue Distribution and Gender-Divergent Expression of 78 Cytochrome P450 mRNAs in Mice
- (2011) Helen J. Renaud et al. TOXICOLOGICAL SCIENCES
- Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids
- (2010) Anne Konkel et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice
- (2010) J. E. Ayala et al. Disease Models & Mechanisms
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Gene ontology analysis for RNA-seq: accounting for selection bias
- (2010) Matthew D Young et al. GENOME BIOLOGY
- The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin Sensitivity
- (2009) Jie Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist
- (2009) N. T. Snider et al. MOLECULAR PHARMACOLOGY
- Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease
- (2009) B. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
- (2009) Naim Alkhouri et al. Expert Review of Gastroenterology & Hepatology
- Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450
- (2008) Maude Fer et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway
- (2008) Robert D. Finn et al. BIOCHEMICAL JOURNAL
- CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme
- (2008) Hongbing Wang et al. CURRENT DRUG METABOLISM
- Forkhead Box A2-Mediated Regulation of Female-Predominant Expression of the Mouse Cyp2b9 Gene
- (2008) T. Hashita et al. DRUG METABOLISM AND DISPOSITION
- The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress
- (2008) Jodi M. Maglich et al. JOURNAL OF LIPID RESEARCH
- Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease
- (2008) Zhou-wen Chen et al. Journal of Zhejiang University-SCIENCE B
- Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR)
- (2008) J.P. Hernandez et al. TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started